Replies to post #654476 on NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

I will make it easier for you to comprehend!

Scenario 1:
MHRA submission in April 2023.
Financing available at much higher share price in Q2 2023
MHRA approval by the end of year.
Pot of money becomes available at MHRA approval by end of 2023.
NICE application goes in Jan 2024.

Scenario 2:
Financing at depressed valuation throughout 2023.
MHRA submission in Jan 2024
NICE application in Jan 2024
MHRA approval in Q3 2024
Pot of money becomes available at MHRA approval in Q3 2024

Which makes sense and is advantageous?